Insider · CIK 0001818261
Thomas Catinazzo
cfoofficer
Files at RLAY (Relay Therapeutics, Inc.). First filing Oct 30, 2024, latest Oct 8, 2026.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 9
$0 bought, $1.3M sold
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
RLAY: Relay Therapeutics, Inc.
RLAYOct 9, 2026 · close 17.88
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 30Weak | Relay Therapeutics, Inc. | $329k 17,717 shares | -14% | +235% from low-10% from high | |
| 37Weak | Relay Therapeutics, Inc. | $336k 17,717 shares | -13% | +379% from low-8% from high | |
| 48Moderate | Relay Therapeutics, Inc. | $158k 21,664 shares | -6% | +276% from low0% from high | |
| 45Moderate | Relay Therapeutics, Inc. | $74k 20,081 shares | -6% | +85% from low-54% from high | |
| 24Weak | Relay Therapeutics, Inc. | $59k 19,191 shares | -5% | +63% from low-60% from high | |
| 17Weak | Relay Therapeutics, Inc. | $14k 4,864 shares | -1% | +5% from low-63% from high | |
| 35Weak | Relay Therapeutics, Inc. | $268k 58,936 shares | -20% | +21% from low-43% from high | |
| 17Weak | Relay Therapeutics, Inc. | $21k 4,865 shares | -2% | - | |
| 24Weak | Relay Therapeutics, Inc. | $55k 9,102 shares | -3% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Oct 6, 2026 | RLAY Relay Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -17,511 | $18.58 | $325k | 105,340 | 4 d ago |
| Oct 6, 2026 | RLAY Relay Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -206 | $19.26 | $3,968 | 105,134 | 4 d ago |
| Sep 8, 2026 | RLAY Relay Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -17,717 | $18.94 | $336k | 122,851 | 33 d ago |
| Oct 28, 2025 | RLAY Relay Therapeutics, Inc. | SOpen-market sale Common Stock | -21,664 | $7.29 | $158k | 313,631 | Oct 30, 2025 |
| Jul 28, 2025 | RLAY Relay Therapeutics, Inc. | SOpen-market sale Common Stock | -1,701 | $3.74 | $6,362 | 353,675 | Jul 30, 2025 |
| Jul 29, 2025 | RLAY Relay Therapeutics, Inc. | SOpen-market sale Common Stock | -18,380 | $3.68 | $68k | 335,295 | Jul 30, 2025 |
| Apr 28, 2025 | RLAY Relay Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -1,709 | $3.17 | $5,418 | 372,858 | Apr 30, 2025 |
| Apr 28, 2025 | RLAY Relay Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -981 | $3.17 | $3,110 | 371,877 | Apr 30, 2025 |
| Apr 29, 2025 | RLAY Relay Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -3,558 | $3.23 | $11k | 368,319 | Apr 30, 2025 |
| Apr 30, 2025 | RLAY Relay Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -12,943 | $3.00 | $39k | 355,376 | Apr 30, 2025 |
| Mar 27, 2025 | RLAY Relay Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -298 | $2.84 | $846 | 379,133 | Mar 31, 2025 |
| Mar 27, 2025 | RLAY Relay Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -4,566 | $2.84 | $13k | 374,567 | Mar 31, 2025 |
| Jan 28, 2025 | RLAY Relay Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -33,753 | $4.63 | $156k | 265,473 | Jan 30, 2025 |
| Jan 28, 2025 | RLAY Relay Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -2,283 | $4.63 | $11k | 263,190 | Jan 30, 2025 |
| Jan 28, 2025 | RLAY Relay Therapeutics, Inc. | AGrant or award Common Stock10b5-1 | +139,141 | $0.00 | $0 | 402,331 | Jan 30, 2025 |
| Jan 29, 2025 | RLAY Relay Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -2,109 | $4.55 | $9,596 | 400,222 | Jan 30, 2025 |
| Jan 30, 2025 | RLAY Relay Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -20,791 | $4.42 | $92k | 379,431 | Jan 30, 2025 |
| Jan 10, 2025 | RLAY Relay Therapeutics, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +275,000 | $0.00 | $0 | 275,000 | Jan 14, 2025 |
| Dec 27, 2024 | RLAY Relay Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -299 | $4.38 | $1,310 | 303,792 | Dec 31, 2024 |
| Dec 27, 2024 | RLAY Relay Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -4,566 | $4.42 | $20k | 299,226 | Dec 31, 2024 |
| Oct 28, 2024 | RLAY Relay Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -1,697 | $6.06 | $10k | 311,496 | Oct 30, 2024 |
| Oct 28, 2024 | RLAY Relay Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -5,105 | $6.06 | $31k | 306,391 | Oct 30, 2024 |
| Oct 29, 2024 | RLAY Relay Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -2,300 | $5.95 | $14k | 304,091 | Oct 30, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.